THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Michael Detamore to Humans

Back to Details
This is a "connection" page, showing publications Michael Detamore has written about Humans.
Michael Detamore
Connection Strength
1.138
Humans
  1. Regenerative rehabilitation with conductive biomaterials for spinal cord injury. Acta Biomater. 2022 02; 139:43-64.
    View in: PubMed
    Score: 0.041
  2. Thiolated bone and tendon tissue particles covalently bound in hydrogels for in vivo calvarial bone regeneration. Acta Biomater. 2020 03 01; 104:66-75.
    View in: PubMed
    Score: 0.038
  3. Chondroinductive Peptides: Drawing Inspirations from Cell-Matrix Interactions. Tissue Eng Part B Rev. 2019 06; 25(3):249-257.
    View in: PubMed
    Score: 0.035
  4. Effects of tissue processing on bioactivity of cartilage matrix-based hydrogels encapsulating osteoconductive particles. Biomed Mater. 2018 03 16; 13(3):034108.
    View in: PubMed
    Score: 0.034
  5. Preclinical Animal Models for Temporomandibular Joint Tissue Engineering. Tissue Eng Part B Rev. 2018 06; 24(3):171-178.
    View in: PubMed
    Score: 0.033
  6. Microsphere-Based Scaffolds in Regenerative Engineering. Annu Rev Biomed Eng. 2017 06 21; 19:135-161.
    View in: PubMed
    Score: 0.032
  7. Cartilage extracellular matrix as a biomaterial for cartilage regeneration. Ann N Y Acad Sci. 2016 11; 1383(1):139-159.
    View in: PubMed
    Score: 0.031
  8. Mechanical evaluation of gradient electrospun scaffolds with 3D printed ring reinforcements for tracheal defect repair. Biomed Mater. 2016 Apr 21; 11(2):025020.
    View in: PubMed
    Score: 0.030
  9. Chondroinductive Hydrogel Pastes Composed of Naturally Derived Devitalized Cartilage. Ann Biomed Eng. 2016 06; 44(6):1863-80.
    View in: PubMed
    Score: 0.029
  10. Stem Cells in Aggregate Form to Enhance Chondrogenesis in Hydrogels. PLoS One. 2015; 10(12):e0141479.
    View in: PubMed
    Score: 0.029
  11. Potential Indications for Tissue Engineering in Temporomandibular Joint Surgery. J Oral Maxillofac Surg. 2016 Apr; 74(4):705-11.
    View in: PubMed
    Score: 0.029
  12. Microsphere-based gradient implants for osteochondral regeneration: a long-term study in sheep. Regen Med. 2015; 10(6):709-28.
    View in: PubMed
    Score: 0.028
  13. Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues. Tissue Eng Part A. 2015 Jun; 21(11-12):1795-809.
    View in: PubMed
    Score: 0.028
  14. The effect of extended passaging on the phenotype and osteogenic potential of human umbilical cord mesenchymal stem cells. Mol Cell Biochem. 2015 Mar; 401(1-2):155-64.
    View in: PubMed
    Score: 0.027
  15. The bioactivity of cartilage extracellular matrix in articular cartilage regeneration. Adv Healthc Mater. 2015 Jan 07; 4(1):29-39.
    View in: PubMed
    Score: 0.026
  16. Improving viability and transfection efficiency with human umbilical cord wharton's jelly cells through use of a ROCK inhibitor. Cell Reprogram. 2014 Apr; 16(2):91-7.
    View in: PubMed
    Score: 0.025
  17. Human umbilical cord mesenchymal stromal cells in regenerative medicine. Stem Cell Res Ther. 2013 Nov 25; 4(6):142.
    View in: PubMed
    Score: 0.025
  18. Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres. Mater Sci Eng C Mater Biol Appl. 2013 Oct; 33(7):4343-51.
    View in: PubMed
    Score: 0.024
  19. Mechanical testing of hydrogels in cartilage tissue engineering: beyond the compressive modulus. Tissue Eng Part B Rev. 2013 Oct; 19(5):403-12.
    View in: PubMed
    Score: 0.024
  20. The future of carbon dioxide for polymer processing in tissue engineering. Tissue Eng Part B Rev. 2013 Jun; 19(3):221-32.
    View in: PubMed
    Score: 0.024
  21. Tailoring of processing parameters for sintering microsphere-based scaffolds with dense-phase carbon dioxide. J Biomed Mater Res B Appl Biomater. 2013 Feb; 101(2):330-7.
    View in: PubMed
    Score: 0.023
  22. Physical non-viral gene delivery methods for tissue engineering. Ann Biomed Eng. 2013 Mar; 41(3):446-68.
    View in: PubMed
    Score: 0.023
  23. Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells. Stem Cells Dev. 2013 Jan 01; 22(1):18-26.
    View in: PubMed
    Score: 0.023
  24. Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine. Tissue Eng Part B Rev. 2012 Oct; 18(5):341-62.
    View in: PubMed
    Score: 0.023
  25. Osteogenic differentiation of human bone marrow stromal cells in hydroxyapatite-loaded microsphere-based scaffolds. Tissue Eng Part A. 2012 Apr; 18(7-8):757-67.
    View in: PubMed
    Score: 0.022
  26. Overview of tracheal tissue engineering: clinical need drives the laboratory approach. Ann Biomed Eng. 2011 Aug; 39(8):2091-113.
    View in: PubMed
    Score: 0.021
  27. Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med. 2011 Jan; 6(1):95-109.
    View in: PubMed
    Score: 0.021
  28. Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering. J Tissue Eng Regen Med. 2011 Oct; 5(9):712-21.
    View in: PubMed
    Score: 0.021
  29. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng Part A. 2010 Jun; 16(6):1937-48.
    View in: PubMed
    Score: 0.020
  30. Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals. Ann Biomed Eng. 2010 Jun; 38(6):2167-82.
    View in: PubMed
    Score: 0.019
  31. Microsphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent. Acta Biomater. 2010 Jan; 6(1):137-43.
    View in: PubMed
    Score: 0.019
  32. Insulin-like growth factor-I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells. J Orthop Res. 2009 Aug; 27(8):1109-15.
    View in: PubMed
    Score: 0.019
  33. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A. 2009 Aug; 15(8):2259-66.
    View in: PubMed
    Score: 0.019
  34. Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med. 2009 Jul; 3(5):398-404.
    View in: PubMed
    Score: 0.018
  35. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng Part A. 2009 May; 15(5):1009-17.
    View in: PubMed
    Score: 0.018
  36. Biomechanical properties of the mandibular condylar cartilage and their relevance to the TMJ disc. J Biomech. 2009 Mar 11; 42(4):405-17.
    View in: PubMed
    Score: 0.018
  37. Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Eng Part B Rev. 2008 Dec; 14(4):341-66.
    View in: PubMed
    Score: 0.018
  38. Tissue engineering the mandibular condyle. Tissue Eng. 2007 Aug; 13(8):1955-71.
    View in: PubMed
    Score: 0.016
  39. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng. 2007 Aug; 13(8):2003-10.
    View in: PubMed
    Score: 0.016
  40. A call to action for bioengineers and dental professionals: directives for the future of TMJ bioengineering. Ann Biomed Eng. 2007 Aug; 35(8):1301-11.
    View in: PubMed
    Score: 0.016
  41. Motivation, characterization, and strategy for tissue engineering the temporomandibular joint disc. Tissue Eng. 2003 Dec; 9(6):1065-87.
    View in: PubMed
    Score: 0.013
  42. Structure and function of the temporomandibular joint disc: implications for tissue engineering. J Oral Maxillofac Surg. 2003 Apr; 61(4):494-506.
    View in: PubMed
    Score: 0.012
  43. Polymer-coated microparticle scaffolds engineered for potential use in musculoskeletal tissue regeneration. Biomed Mater. 2021 05 24; 16(4).
    View in: PubMed
    Score: 0.011
  44. Human platelet lysate-based nanocomposite bioink for bioprinting hierarchical fibrillar structures. Biofabrication. 2019 11 27; 12(1):015012.
    View in: PubMed
    Score: 0.010
  45. A Protocol for Decellularizing Mouse Cochleae for Inner Ear Tissue Engineering. J Vis Exp. 2018 01 01; (131).
    View in: PubMed
    Score: 0.008
  46. Exploiting decellularized cochleae as scaffolds for inner ear tissue engineering. Stem Cell Res Ther. 2017 02 28; 8(1):41.
    View in: PubMed
    Score: 0.008
  47. Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications. PLoS One. 2017; 12(2):e0172098.
    View in: PubMed
    Score: 0.008
  48. Species-specific effects of aortic valve decellularization. Acta Biomater. 2017 03 01; 50:249-258.
    View in: PubMed
    Score: 0.008
  49. Hyaluronic-Acid-Hydroxyapatite Colloidal Gels Combined with Micronized Native ECM as Potential Bone Defect Fillers. Langmuir. 2017 01 10; 33(1):206-218.
    View in: PubMed
    Score: 0.008
  50. Nanoengineered biomaterials for repair and regeneration of orthopedic tissue interfaces. Acta Biomater. 2016 09 15; 42:2-17.
    View in: PubMed
    Score: 0.007
  51. Emerging Trends in Biomaterials Research. Ann Biomed Eng. 2016 06; 44(6):1861-2.
    View in: PubMed
    Score: 0.007
  52. Engineering and commercialization of human-device interfaces, from bone to brain. Biomaterials. 2016 07; 95:35-46.
    View in: PubMed
    Score: 0.007
  53. The Use of Human Wharton's Jelly Cells for Cochlear Tissue Engineering. Methods Mol Biol. 2016; 1427:319-45.
    View in: PubMed
    Score: 0.007
  54. Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineering. Tissue Eng Part A. 2013 Dec; 19(23-24):2586-93.
    View in: PubMed
    Score: 0.006
  55. Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype. Cell Reprogram. 2013 Feb; 15(1):43-54.
    View in: PubMed
    Score: 0.006
  56. Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold. Tissue Eng Part A. 2011 Apr; 17(7-8):969-79.
    View in: PubMed
    Score: 0.005
  57. PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J Biomed Mater Res A. 2011 Mar 01; 96(3):520-7.
    View in: PubMed
    Score: 0.005
  58. Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Eng Part A. 2010 Sep; 16(9):2743-53.
    View in: PubMed
    Score: 0.005
  59. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng Part C Methods. 2008 Dec; 14(4):299-309.
    View in: PubMed
    Score: 0.004
  60. Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res. 2008 Apr; 87(4):296-307.
    View in: PubMed
    Score: 0.004
  61. Lubrication of the temporomandibular joint. Ann Biomed Eng. 2008 Jan; 36(1):14-29.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES